These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22981710)
1. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery. Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921 [TBL] [Abstract][Full Text] [Related]
3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
4. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01). Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540 [TBL] [Abstract][Full Text] [Related]
7. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation. Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy. Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192 [TBL] [Abstract][Full Text] [Related]
9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780 [TBL] [Abstract][Full Text] [Related]
10. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Janjan NA; Delclos ME; Krishnan S; Levy LB; Ellis LM; Crane CH Am J Clin Oncol; 2006 Jun; 29(3):219-24. PubMed ID: 16755173 [TBL] [Abstract][Full Text] [Related]
12. The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma. Edden Y; Wexner SD; Berho M Colorectal Dis; 2012 May; 14(5):555-61. PubMed ID: 21689364 [TBL] [Abstract][Full Text] [Related]
13. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
14. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650 [TBL] [Abstract][Full Text] [Related]
16. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833 [TBL] [Abstract][Full Text] [Related]
17. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E; Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570 [TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Edler D; Hallström M; Johnston PG; Magnusson I; Ragnhammar P; Blomgren H Clin Cancer Res; 2000 Apr; 6(4):1378-84. PubMed ID: 10778966 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence. An HJ; Yu CS; Yun SC; Kang BW; Hong YS; Lee JL; Ryu MH; Chang HM; Park JH; Kim JH; Kang YK; Kim JC; Kim TW Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):73-80. PubMed ID: 22300562 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment for locally advanced rectal cancer patients after preoperative chemoradiotherapy: when, and for whom? De Stefano A; Moretto R; Bucci L; Pepe S; Romano FJ; Cella AC; Attademo L; Rosanova M; De Falco S; Fiore G; Raimondo L; De Placido S; Carlomagno C Clin Colorectal Cancer; 2014 Sep; 13(3):185-91. PubMed ID: 25080847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]